1. Home
  2. SILO vs UPXI Comparison

SILO vs UPXI Comparison

Compare SILO & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • UPXI
  • Stock Information
  • Founded
  • SILO 2010
  • UPXI 2018
  • Country
  • SILO United States
  • UPXI United States
  • Employees
  • SILO N/A
  • UPXI N/A
  • Industry
  • SILO Apparel
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • SILO Consumer Discretionary
  • UPXI Health Care
  • Exchange
  • SILO Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • SILO 5.9M
  • UPXI 481.8M
  • IPO Year
  • SILO N/A
  • UPXI 2021
  • Fundamental
  • Price
  • SILO $0.65
  • UPXI $6.76
  • Analyst Decision
  • SILO
  • UPXI
  • Analyst Count
  • SILO 0
  • UPXI 0
  • Target Price
  • SILO N/A
  • UPXI N/A
  • AVG Volume (30 Days)
  • SILO 303.5K
  • UPXI 6.0M
  • Earning Date
  • SILO 11-11-2025
  • UPXI 05-16-2025
  • Dividend Yield
  • SILO N/A
  • UPXI N/A
  • EPS Growth
  • SILO N/A
  • UPXI N/A
  • EPS
  • SILO N/A
  • UPXI N/A
  • Revenue
  • SILO $72,102.00
  • UPXI $16,562,327.00
  • Revenue This Year
  • SILO $1.86
  • UPXI $299.03
  • Revenue Next Year
  • SILO N/A
  • UPXI N/A
  • P/E Ratio
  • SILO N/A
  • UPXI N/A
  • Revenue Growth
  • SILO N/A
  • UPXI 1378.83
  • 52 Week Low
  • SILO $0.41
  • UPXI $1.90
  • 52 Week High
  • SILO $3.37
  • UPXI $22.57
  • Technical
  • Relative Strength Index (RSI)
  • SILO 51.35
  • UPXI 51.91
  • Support Level
  • SILO $0.58
  • UPXI $5.20
  • Resistance Level
  • SILO $0.70
  • UPXI $5.99
  • Average True Range (ATR)
  • SILO 0.04
  • UPXI 0.74
  • MACD
  • SILO 0.00
  • UPXI -0.16
  • Stochastic Oscillator
  • SILO 61.44
  • UPXI 39.72

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.

Share on Social Networks: